Alector is focused on developing innovative therapies for neurodegenerative diseases using its proprietary Alector Brain Carrier (ABC) technology
Alector is focused on developing innovative therapies for neurodegenerative diseases using its proprietary Alector Brain Carrier (ABC) technology. The company combines expertise in human genetics, immunology, neuroscience, and artificial intelligence to create therapies that can effectively penetrate the blood-brain barrier.